Our mission,
The development of a radiopharmaceutical for molecular imaging with Positon Emission Tomography (PET) in cardiology and oncology.

 

« and this, we’re not used to have this kind of information in a clinical base and on every patients. This would changed completely a way of better evaluating patients with tri-vessel disease but also have a better view of microvascular disease. »

Discover his video